IRIS
GIULIANI, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.776
AS - Asia 11.361
EU - Europa 8.315
SA - Sud America 1.665
AF - Africa 593
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 5
Totale 34.737
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.376
SG - Singapore 4.848
CN - Cina 3.795
IE - Irlanda 1.617
SE - Svezia 1.518
BR - Brasile 1.348
FI - Finlandia 1.128
DE - Germania 923
IT - Italia 881
HK - Hong Kong 876
VN - Vietnam 664
UA - Ucraina 640
TR - Turchia 501
NL - Olanda 401
ZA - Sudafrica 392
CA - Canada 274
GB - Regno Unito 266
FR - Francia 229
RU - Federazione Russa 176
IN - India 159
AR - Argentina 135
AT - Austria 119
BD - Bangladesh 102
CI - Costa d'Avorio 89
MX - Messico 76
RO - Romania 68
BE - Belgio 64
JP - Giappone 62
PL - Polonia 61
CZ - Repubblica Ceca 55
EC - Ecuador 53
IQ - Iraq 51
ES - Italia 50
KR - Corea 49
LT - Lituania 33
PK - Pakistan 33
ID - Indonesia 30
CO - Colombia 28
MA - Marocco 26
UZ - Uzbekistan 26
VE - Venezuela 25
PY - Paraguay 23
AE - Emirati Arabi Uniti 21
IR - Iran 20
EU - Europa 18
UY - Uruguay 16
CL - Cile 15
IL - Israele 15
KE - Kenya 14
PE - Perù 14
BG - Bulgaria 13
CR - Costa Rica 12
EG - Egitto 12
TN - Tunisia 12
JO - Giordania 10
KZ - Kazakistan 10
AL - Albania 9
SA - Arabia Saudita 9
BO - Bolivia 8
ET - Etiopia 8
HU - Ungheria 8
QA - Qatar 8
DO - Repubblica Dominicana 7
NG - Nigeria 7
OM - Oman 7
CH - Svizzera 6
LV - Lettonia 6
MY - Malesia 6
PA - Panama 6
PH - Filippine 6
SN - Senegal 6
AM - Armenia 5
AZ - Azerbaigian 5
DZ - Algeria 5
JM - Giamaica 5
MD - Moldavia 5
NP - Nepal 5
TT - Trinidad e Tobago 5
BY - Bielorussia 4
DK - Danimarca 4
EE - Estonia 4
HN - Honduras 4
KG - Kirghizistan 4
KH - Cambogia 4
LB - Libano 4
LU - Lussemburgo 4
PS - Palestinian Territory 4
PT - Portogallo 4
RS - Serbia 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
TW - Taiwan 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
AU - Australia 3
BN - Brunei Darussalam 3
CM - Camerun 3
GA - Gabon 3
GR - Grecia 3
Totale 34.696
Salva come PNG Salva come JPEG
Città #
Singapore 2.443
Ashburn 1.645
Chandler 1.645
Dublin 1.609
Beijing 1.005
Santa Clara 873
Hong Kong 868
Dallas 840
Jacksonville 761
Boardman 496
Nanjing 409
Izmir 405
Dearborn 382
Parma 374
Johannesburg 370
Ann Arbor 346
Princeton 323
Shanghai 318
Los Angeles 304
Ho Chi Minh City 255
New York 251
San Mateo 233
Munich 213
Wilmington 186
Toronto 162
Shenyang 159
Hefei 156
Kunming 147
Marseille 137
Nanchang 137
Helsinki 131
São Paulo 131
Hanoi 130
Düsseldorf 125
Jinan 106
Columbus 105
Hebei 105
Vienna 98
Moscow 97
Buffalo 93
Abidjan 89
Des Moines 87
Tianjin 86
Jiaxing 78
Turku 78
Bremen 74
Seattle 70
Changsha 64
Brussels 63
Tokyo 61
The Dalles 60
Warsaw 54
Woodbridge 54
Kocaeli 52
Council Bluffs 51
Montreal 50
Guangzhou 48
Houston 47
Seoul 47
Hangzhou 45
London 44
Pune 44
Rio de Janeiro 44
Brooklyn 43
Phoenix 42
Milan 41
Focsani 39
Poplar 39
Brno 37
Norwalk 37
Orem 36
Stockholm 36
Nuremberg 35
Atlanta 34
Zhengzhou 34
Denver 33
Amsterdam 29
Chicago 29
Da Nang 29
Frankfurt am Main 29
Grafing 29
Boston 28
Chennai 26
San Jose 26
Haiphong 25
San Francisco 25
Ankara 24
Redondo Beach 24
Belo Horizonte 23
Tashkent 23
Brasília 22
Mexico City 22
Rome 22
Fremont 21
Guarulhos 21
Mestre 21
Augusta 20
Bologna 20
Jakarta 20
Ningbo 20
Totale 21.027
Salva come PNG Salva come JPEG
Nome #
Are the Myeloma bone microevironment cells tumoral or not? 196
Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma 196
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 182
Angiopoietin-1 and Osteopontin Expression by CD138+ Myeloma Cells Rather Than VEGF and CD45 Correlates with Bone Marrow Angiogenesis in Multiple Myeloma Patients at the Diagnosis 181
Bone marrow CX3CL1/Fractalkine is a new player of the pro-angiogenic microenvironment in multiple myeloma patients 180
A simplified sars-cov-2 pseudovirus neutralization assay 179
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? 173
(2S,4R)-4-fluoroglutamine is converted into (2S,4R)-4-fluoroglutamate by glutaminase activity and may be exploited as a PET tracer in glutamine-addicted cancers 172
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 170
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients 167
Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo 165
CD14+CD16+ monocytes are involved in daratumumab-mediated myeloma cells killing and in anti-CD47 therapeutic strategy 165
The Proteasome and Myeloma-Associated Bone Disease 164
Application of next-generation sequencing for the genomic characterization of patients with smoldering myeloma 163
Hypoxia and Hypoxia Inducible Factor (HIF)-1{alpha} in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment 162
Novel targets for the treatment of relapsing multiple myeloma 162
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis 162
[18F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma 162
CC-4047 (Pomalidomide) inhibits multiple myeloma-induced osteoclast formation targeting RANKL in the bone marrow microenvironment 160
Hypoxia-Inducible Factor (HIF)-1 alpha Inhibitionin Myeloma Cells Significantly Increases the Anti-Myeloma Effect of Lenalidomide in Vivo 160
Activation of non-canonical wnt pathway in human mesenchymal cells affects osteogenic differentiation: a potential target in Multiple Myeloma microenvironment 157
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia 157
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma 157
The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment 156
HOXB7 is a key gene involved in Myeloma cell growth and Myeloma-induced angiogenesis in Multiple Myeloma patients 154
Chemokine receptors CXCR3 and CXCR4 expression in B cell and plasma cell malignancy 152
5-HT3 serotonergic receptor mediation of hypoglycemia-induced arginine-vasopressin but not oxytocin secretion in normal men. 152
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy 149
Hypoxia and hypoxia inducible factor (HIF)-1α in Multiple Myeloma patients: role in the angiogenic switch 149
The Immunomodulatory drugs Lenalidomide and Pomalidomide inhibit multiple myeloma-induced osteoclast formation and RANKL/OPG ratio in myeloma microenvironment targeting the expression of adhesion molecules 148
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 148
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 147
Bisphosphonates inhibit IL-6 production by human osteoblast-like cells 145
Oxygen tension in the bone marrow (BM) of patients with malignant and indolent monoclonal gammopathy: role of hypoxia and hypoxia-inducible factor (HIF)-1{alpha} in the regulation of gene expression and pro-angiogenic profiles of CD138+ cells 145
Addition of Bortezomib to High Dose Melphalan As Conditioning Regimen for Autologous Stem Cell Transplantation Improves the Response Rate in Newly Diagnosed Multiple Myeloma Patients 145
Role of 1q21 in multiple myeloma: From pathogenesis to possible therapeutic targets 143
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 142
Functional consequences of low activity of transport system a for neutral amino acids in human bone marrow mesenchymal stem cells 142
Bortezomib improves bone integrity in multiple myeloma patients by blocking osteocyte death and autophagy 141
A Mouse Model of Telomere Dysfunction Recapitulates Hallmark Features of Human Myelodysplastic Syndrome 141
HOXB7 is critically involved in Multiple Myeloma-induced angiogenic switch 140
Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells 139
The homeobox gene HOXB7 regulates the production of pro-angiogenic molecole by myeloma cells and it is a target in myeloma-induced angiogenesis 139
Myeloma cells inhibit the non-canonical wnt co-receptor ror2 in human mesenchymal/osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on mm-induced impairment of the osteogenic differentiation process 138
GPNA inhibits the sodium-independent transport system l for neutral amino acids 138
Angiopoietins expression by human myeloma cells 137
Phase II Study of the Combination of Interleukin-2 with Zoledronic Acid As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma 137
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 137
Glutamine dependence and PIK3CA mutations in colon-rectal cancer cells: ATF4 enters the stage 136
Amlexanox inhibition of TBK1/IKK epsilon Signaling Is a Novel Therapeutic Approach for Multiple Myeloma-Induced Bone Disease. 136
The IMID CC-4047 (Pomalidomide) inhibits myeloma-induced osteoclast formation 136
LENALIDOMIDE INCREASES HUMAN DENDRITIC CELL MATURATION MODULATING BOTH MONOCYTE DIFFERENTIATION AND MESENCHYMAL STROMAL CELL INHIBITORY PROPERTIES 136
Pro-angiogenetic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 135
Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin? 134
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 134
A translocation t(4;13)(q21;q14) as single clonal chromosomal abnormality in a parathyroid adenoma 134
ADENOSINE IN THE MYELOMA BONE MARROW NICHE: IMMUNE CHECKPOINT AND KEY PLAYER IN DISEASE PROGRESSION 133
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 132
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo 132
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability 132
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy 132
IL-7 is induced by IL-6 in human myeloma cells: role in multiple myeloma 131
In vitro and In vivo evidences of osteocytes involvement in myeloma-induced osteolysis 131
ILF2-YB1 Protein Interaction Modulates RNA Splicing to Induce Resistance to Chemotherapy in High Risk Multiple Myeloma 131
Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking 130
CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival. 130
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes 130
Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL 130
Galectin-1 Is Highly Expressed By Myeloma Cells and the Bone Marrow Microenvironment and Its Suppression Delineates a New Therapeutic in Vitro and in Vivo Strategy in Multiple Myeloma 130
Autologous bone marrow transplantation in acute myeloid leukemia: a single center experience 130
Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma 129
Angiopoietin-1 and osteopontin expression by CD138+myeloma cells rather than VEGF and CD45 correlates with bone marrow angiogenesis in Multiple Myeloma patients at the diagnosis. 129
Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity 129
Generation and Characterization of Microvesicles after Daratumumab Interaction with Myeloma Cells 128
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 128
Angiopoietin-1 and myeloma-induced angiogenesis 127
Concomitant primary hyperparathyroidism in patients with multiple myeloma: A possible link? 127
BCR/ABL fusion gene is detected in chronic myeloid leukemia endothelial cells 127
Adenosine Generated in the Bone Marrow Niche Through a CD38-Mediated Pathway Correlates with Progression of Human Myeloma. 127
Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients 126
Human myeloma cells produce angiopoietin-1 but not angiopoietin-2: potential relationship with myeloma-induced angiogenesis 126
Oncolytic virotherapy and microenvironment in multiple myeloma 126
The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells 126
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients 126
Angiogenic switch in multiple myeloma patients 125
Analysis of lineage involvment in Philadelphia chromosome positive acute lymphoblastic leukaemia 125
Arginine Vasopressin and Oxytocin responses to angiotensin II are mediated by AT1 receptor subtype in normal men 125
Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma 124
Angiogenic properties of human myeloma cells: role of angiopoietin system 124
Bone marrow CD14+ cells show different transcriptional profiles in Multiple Myeloma (MM) as compared to smoldering MM and MGUS: overexpression of IL21R and its involvement in osteoclastogenesis 124
Ectopic production of osteopontin by human myeloma cells and its involvement in myeloma induced angiogenesis 124
Non canonical wnt signal pathway (Wnt5a/ror2) activation stimulates the osteogenic differentiation process of bone mesenchymal cells being a potential target in multiple myeloma bone disease 123
Bone marrow monocyte / macrophage derived activin a mediates the osteoclastogenic effects of IL-3 in myeloma 123
Bone marrow stromal cell-fueled multiple myeloma growth and osteoclastogenesis are sustained by protein kinase CK2 123
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 123
Telomere Dysfunction Drives Aberrant Hematopoietic Differentiation and Myelodysplastic Syndrome 122
Increased osteocyte apoptosis in Multiple Myeloma patients: a potential role in bone remodeling alterations related to osteolytic bone lesions 121
Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients 121
The new tumor suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of pro-angiogenic molecules by myeloma cells and suppresses hypoxia inducible factor (HIF)-1{alpha} activity being involved in myeloma-induced angiogenesis. 121
The osteoblastic niche in the context of multiple myeloma 120
Totale 14.160
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.398
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.398
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.038 0 0 0 0 0 24 144 47 377 87 292 67
2021/20221.590 31 23 26 110 37 57 199 202 77 145 128 555
2022/20236.260 724 647 387 452 535 671 158 400 1.960 74 187 65
2023/20242.283 110 237 55 58 191 623 195 163 54 126 152 319
2024/20257.397 118 403 435 583 801 690 288 320 985 669 633 1.472
2025/20269.714 1.428 1.468 2.040 1.520 2.353 905 0 0 0 0 0 0
Totale 35.187